The health department says drug company ViiV Healthcare's non-profit price for their anti-HIV jab, CAB-LA, is about four times what it can afford to pay. The health department says ViiV Healthcare's newly announced non-profit price — between R540 and R570 per shot — for a two-monthly anti-HIV jab is more than thrice what it can afford to pay. "We've asked ViiV for a quote in South African rands that includes transport and logistics, as we do with all our other tenders. Warren, and several South African HIV researchers, says Pepfar has told them that South Africa is on the list for donations for programmatic use in early 2024. More than a million people in South Africa have used the pill, which was introduced in 2016.

Source: News 24 November 18, 2023 10:51 UTC